Skin and skin structure infection

Sep 26, 2019

Acute Bacterial Skin and Skin Structure Infections Pipeline Insight Report 2019

Jul 12, 2019

More Than Skin Deep: Understanding the Dangers of Cellulitis

Apr 03, 2019

Correvio Announces Xydalba(TM) (Dalbavancin Hydrochloride) Abstracts at ECCMID 2019

Nov 26, 2018

MicuRx Enrolls First Patient in a Phase 2 Clinical Trial in U.S. for Novel Antibiotic, Contezolid Acefosamil

Oct 11, 2018

MMS Submission Support for Paratek Pharmaceuticals Garners FDA Approval and Successful MAA Filing of NUZYRA(TM) (Omadacycline)

Mar 22, 2018

Health Canada Accepts Cardiome's Xydalba New Drug Submission and Grants Priority Review

Dec 11, 2017

Cardiome Announces Xydalba(TM) Treatment And Patient Experience Presentations At The 2017 National Opat Conference

Oct 30, 2017

Cardiome Announces Commercial Launch of Xydalba(TM) in Three New European Geographies

Jun 21, 2017

Cardiome Announces Licensing Agreement for XYDALBA(TM) (Dalbavancin Hydrochloride) to Support Planned Commercialization in Israel

Jun 02, 2017

NovaDigm Therapeutics Awarded $6 Million by U.S. Department of Defense to Conduct a Phase 2a Staphylococcus aureus Vaccine Trial